What is Innate Pharma S.A.?
operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and peripheral T-cell lymphoma; IPH4502, a novel and differentiated topoisomerase I inhibitor ADC conjugated to exatecan targeting Nectin-4; and Monalizumab, a dual checkpoint inhibitor that targets T Cells and NK Cells. The company is listed on the LSE in UK, operating in the Healthcare sector, with a market capitalisation of 193.88M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.